Return to Results

Phase II study of Docetaxel and atrasentan versus docetaxel and placebo for patients with advanced hormone refractory prostate cancer.

new search

Trial Conditions
  • Prostate Cancer
What is the purpose of this trial?

The purpose of this study is to compare the effects (good and bad) of the combination of docetaxel and prednisone plus atrasentan against the combination of docetaxel and prednisone plus placebo in patients with prostate cancer to see which is better.

Date & Status


Other Information

Sponsor: National Cancer Institute, SWOG
Phase: Phase 2
Trial ID: CGS026
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2015 Steward Health Care
Connect Healthcare Panacea CMS Solutions